The report will be delivered in 2-3 business days.

Oncology Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Starting Price : $ 4000.00 | Pages : 150 | Published : May 2020 | SKU CODE : 8386 | Format :


The oncology drugs market consists of sales of oncology drugs and related services by entities (organizations, sole traders and partnerships) that produce oncology drugs to diagnose and treat all types of cancers. This industry includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating pancreatic cancer, breast cancer, ovarian cancer, gastric cancer, kidney cancer, brain tumor, and other cancer types.

The global oncology drugs market is expected to decline from $84.4 billion in 2019 to $75.5 billion in 2020 at a compound annual growth rate (CAGR) of -10.6%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. Hospitals across the world have postponed the chemo treatments for cancer patients due to covid positive cases in the hospitals. The sessions are delayed or postponed to prevent patients and staff from unnecessary exposure. The cancer treatment can lower the patient`s ability to fight infection. COVID-19 pandemic is affecting industries across the globe including the pharmaceutical sector. The disruptions due to extended factory closures in various countries, shortage of APIs and other chemicals, rise in prices of key ingredients, and slowed production are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 8% from 2021 and reach $113.7 billion in 2023.

North America was the largest region in the global oncology drugs market, accounting for 35% of the market in 2019. Asia Pacific was the second largest region accounting for 34% of the global oncology drugs market. Africa was the smallest region in the global oncology drugs market.

Companies are increasingly using cancer biomarkers in the drug development process. Cancer biomarkers are molecules secreted by a tumor or a specific response of the body to the presence of cancer. Identifying and targeting these can enhance cancer detection and facilitate high-speed noninvasive diagnosis using genomics and proteomics tools. It can also help predict the drug efficacy faster than conventional clinical endpoints, the point at which an undesired or abnormal effect of the drug is observed indicating withdrawal from therapy. Companies in this market are investing in the development of biomarkers for use in various activities such as tracking drug activity, the pharmacodynamics of drugs and to study diseases and treatment pathways. For instance, Nektar Therapeutics is developing and using biomarkers in drug development processes of its pipeline drugs NKTR-214 and NKTR-181. Janssen’s research & development is also focusing on identifying predictive markers or stratification markers to help target the new therapies.

The major players in the global oncology drugs market are  F. Hoffmann-La Roche Ltd, Novartis AG, Gilead Sciences Inc, Bayer AG, Takeda Pharmaceticals

The countries covered in the global oncology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

The global oncology drugs market is segmented: 1) By Type, Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma) 2) By Distribution Channel, Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route Of Administration, Oral, Parenteral, Others 4) By Drug Classification, Branded Drugs, Generic Drugs 5) By Mode Of Purchase, Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Oncology Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Oncology Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Oncology Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Oncology Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Oncology Drugs Market Trends And Strategies

    8. Oncology Drugs Market Size And Growth

    8.1. Market Size

    8.2. Historic Market Growth, Value ($ Billion)

    8.2.1. Drivers Of The Market

    8.2.2. Restraints On The Market

    8.3. Forecast Market Growth, Value ($ Billion)

    8.3.1. Drivers Of The Market

    8.3.2. Restraints On The Market

    9. Oncology Drugs Market Regional Analysis

    9.1. Global Oncology Drugs Market, 2019, By Region, Value ($ Billion)

    9.2. Global Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    9.3. Global Oncology Drugs Market, Growth And Market Share Comparison, By Region

    10. Oncology Drugs Market Segmentation

    10.1. Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Lung Cancer

    Pancreatic Cancer

    Breast Cancer

    Prostate Cancer

    Ovarian Cancer

    Colorectal Cancer

    Gastric Cancer

    Kidney Cancer

    Brain Tumor

    Thyroid Cancer

    Skin Cancer

    Bladder Cancer

    Cervical Cancer

    Blood Cancer

    Others (Kaposi Sarcoma, AIDS-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma)

    10.2. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    10.3. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    10.4. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    10.5. Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    11. Oncology Drugs Market Metrics

    11.1. Oncology Drugs Market Size, Percentage Of GDP, 2015-2023, Global

    11.2. Per Capita Average Oncology Drugs Market Expenditure, 2015-2023, Global

    12. Asia-Pacific Oncology Drugs Market

    12.1. Asia-Pacific Oncology Drugs Market Overview

    12.2. Asia-Pacific, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    12.3. Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    12.4. Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    12.5. Asia-Pacific, Oncology Drugs Market Metrics

    12.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Asia-Pacific Countries

    12.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Asia-Pacific Countries

    12.6. Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7. Asia-Pacific Oncology Drugs Market: Country Analysis

    12.7.1. China Oncology Drugs Market

    12.7.1.1. China Oncology Drugs Market Overview

    12.7.1.2. China Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.1.3. China Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2. Australia Oncology Drugs Market

    12.7.2.1. Australia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.2.2. Australia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.3. Hong Kong Oncology Drugs Market

    12.7.3.1. Hong Kong Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4. India Oncology Drugs Market

    12.7.4.1. India Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.4.2. India Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5. Indonesia Oncology Drugs Market

    12.7.5.1. Indonesia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.5.2. Indonesia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6. Japan Oncology Drugs Market

    12.7.6.1. Japan Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.6.2. Japan Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.7. Malaysia Oncology Drugs Market

    12.7.7.1. Malaysia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.8. New Zealand Oncology Drugs Market

    12.7.8.1. New Zealand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.9. Philippines Oncology Drugs Market

    12.7.9.1. Philippines Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.10. Singapore Oncology Drugs Market

    12.7.10.1. Singapore Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11. South Korea Oncology Drugs Market

    12.7.11.1. South Korea Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.11.2. South Korea Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.12. Thailand Oncology Drugs Market

    12.7.12.1. Thailand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    12.7.13. Vietnam Oncology Drugs Market

    12.7.13.1. Vietnam Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13. Western Europe Oncology Drugs Market

    13.1. Western Europe Oncology Drugs Market Overview

    13.2. Western Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    13.3. Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    13.4. Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Western Europe, Oncology Drugs Market Metrics

    13.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Western Europe Countries

    13.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Western Europe Countries

    13.6. Western Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7. Western Europe Oncology Drugs Market: Country Analysis

    13.7.1. Austria Oncology Drugs Market

    13.7.1.1. Austria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.2. Belgium Oncology Drugs Market

    13.7.2.1. Belgium Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.3. Denmark Oncology Drugs Market

    13.7.3.1. Denmark Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.4. Finland Oncology Drugs Market

    13.7.4.1. Finland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5. France Oncology Drugs Market

    13.7.5.1. France Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.5.2. France Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6. Germany Oncology Drugs Market

    13.7.6.1. Germany Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.6.2. Germany Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.7. Ireland Oncology Drugs Market

    13.7.7.1. Ireland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.8. Italy Oncology Drugs Market

    13.7.8.1. Italy Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.9. Netherlands Oncology Drugs Market

    13.7.9.1. Netherlands Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.10. Norway Oncology Drugs Market

    13.7.10.1. Norway Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.11. Portugal Oncology Drugs Market

    13.7.11.1. Portugal Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.12. Spain Oncology Drugs Market

    13.7.12.1. Spain Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.13. Sweden Oncology Drugs Market

    13.7.13.1. Sweden Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.14. Switzerland Oncology Drugs Market

    13.7.14.1. Switzerland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15. UK Oncology Drugs Market

    13.7.15.1. UK Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    13.7.15.2. UK Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14. Eastern Europe Oncology Drugs Market

    14.1. Eastern Europe Oncology Drugs Market Overview

    14.2. Eastern Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    14.3. Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    14.4. Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Eastern Europe, Oncology Drugs Market Metrics

    14.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Eastern Europe Countries

    14.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Eastern Europe Countries

    14.6. Eastern Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7. Eastern Europe Oncology Drugs Market: Country Analysis

    14.7.1. Czech Republic Oncology Drugs Market,  

    14.7.1.1. Czech Republic Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.2. Poland Oncology Drugs Market

    14.7.2.1. Poland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.3. Romania Oncology Drugs Market

    14.7.3.1. Romania Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4. Russia Oncology Drugs Market

    14.7.4.1. Russia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    14.7.4.2. Russia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15. North America Oncology Drugs Market

    15.1. North America Oncology Drugs Market Overview

    15.2. North America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    15.3. North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    15.4. North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. North America, Oncology Drugs Market Metrics

    15.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, North America Countries

    15.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, North America Countries

    15.6. North America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7. North America Oncology Drugs Market: Country Analysis

    15.7.1. Canada Oncology Drugs Market

    15.7.1.1. Canada Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.2. Mexico Oncology Drugs Market

    15.7.2.1. Mexico Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3. USA Oncology Drugs Market

    15.7.3.1. USA Oncology Drugs Market Overview

    15.7.3.2. USA Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    15.7.3.3. USA Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16. South America Oncology Drugs Market

    16.1. South America Oncology Drugs Market Overview

    16.2. South America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    16.3. South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    16.4. South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. South America, Oncology Drugs Market Metrics

    16.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, South America Countries

    16.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, South America Countries

    16.6. South America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7. South America Oncology Drugs Market: Country Analysis

    16.7.1. Argentina Oncology Drugs Market

    16.7.1.1. Argentina Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2. Brazil Oncology Drugs Market

    16.7.1.1. Brazil Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.2.2. Brazil Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.3. Chile Oncology Drugs Market

    16.7.3.1. Chile Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.4. Colombia Oncology Drugs Market

    16.7.4.1. Colombia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.5. Peru Oncology Drugs Market

    16.7.5.1. Peru Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    16.7.6. Venezuela Oncology Drugs Market

    16.7.6.1. Venezuela Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17. Middle East Oncology Drugs Market

    17.1. Middle East Oncology Drugs Market Overview

    17.2. Middle East, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    17.3. Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    17.4. Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. Middle East, Oncology Drugs Market Metrics

    17.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Middle East Countries

    17.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Middle East Countries

    17.6. Middle East Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7. Middle East Oncology Drugs Market: Country Analysis

    17.7.1. Saudi Arabia Oncology Drugs Market

    17.7.1.1. Saudi Arabia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.2. Israel Oncology Drugs Market

    17.7.2.1. Israel Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.3. Turkey Oncology Drugs Market

    17.7.3.1. Turkey Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    17.7.4. UAE Oncology Drugs Market

    17.7.4.1. UAE Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18. Africa Oncology Drugs Market

    18.1. Africa Oncology Drugs Market Overview

    18.2. Africa, Oncology Drugs Market, 2019, By Country, Value ($ Billion)

    18.3. Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country

    18.4. Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Africa, Oncology Drugs Market Metrics

    18.5.1. Per Capita Average Oncology Drugs Expenditure, 2015-2023, Africa Countries

    18.5.2. Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Africa Countries

    18.6. Africa Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7. Africa Oncology Drugs Market: Country Analysis

    18.7.1. Egypt Oncology Drugs Market

    18.7.1.1. Egypt Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.2. Nigeria Oncology Drugs Market

    18.7.2.1. Nigeria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    18.7.3. South Africa Oncology Drugs Market

    18.7.3.1. South Africa Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

    19. Oncology Drugs Market Competitive Landscape

    19.1. Competitive Market Overview

    19.2. Market Shares

    19.3. Company Profiles

    19.3.1. F. Hoffmann-La Roche Ltd

    19.3.1.1. Company Overview

    19.3.1.2. Products And Services

    19.3.1.3. Strategy

    19.3.1.4. Financial Performance

    19.3.2. Novartis AG

    19.3.2.1. Company Overview

    19.3.2.2. Products And Services

    19.3.2.3. Strategy

    19.3.2.4. Financial Performance

    19.3.3. Gilead Sciences Inc

    19.3.3.1. Company Overview

    19.3.3.2. Products And Services

    19.3.3.3. Strategy

    19.3.3.4. Financial Performance

    19.3.4. Bayer AG

    19.3.4.1. Company Overview

    19.3.4.2. Products And Services

    19.3.4.3. Strategy

    19.3.4.4. Financial Performance

    19.3.5. Takeda Pharmaceticals

    19.3.5.1. Company Overview

    19.3.5.2. Products And Services

    19.3.5.3. Strategy

    19.3.5.4. Financial Performance

    20. Key Mergers And Acquisitions In The Oncology Drugs Market

    21. Market Background: Pharmaceutical Drugs Market

    21.1. Pharmaceutical Drugs Market Characteristics

    21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)

    21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region

    21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

    22. Recommendations

    22.1. Global Oncology Drugs Market In 2023- Growth Countries

    22.2. Global Oncology Drugs Market In 2023- Growth Segments

    22.3. Global Oncology Drugs Market In 2023- Growth Strategies

    23. Appendix

    23.1. NAICS Definitions Of Industry Covered In This Report

    23.2. Abbreviations

    23.3. Currencies

    23.4. Research Inquiries

    23.5. The Business Research Company

    24. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Oncology Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 4: Global Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Oncology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Table 12: Per Capita Average Oncology Drugs Market Expenditure, 2015-2023, Global
  • Table 13: Asia-Pacific, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Table 17: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Asia-Pacific Countries
  • Table 18: Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 19: China Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 20: China Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 22: Australia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 23: Hong Kong Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 24: India Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 25: India Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 27: Indonesia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 29: Japan Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 30: Malaysia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 31: New Zealand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 32: Philippines Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 33: Singapore Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 34: South Korea Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 35: Thailand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 36: Vietnam Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 37: Western Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 38: Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 39: Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 40: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Western Europe Countries
  • Table 41: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Western Europe Countries
  • Table 42: Western Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 43: Austria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 44: Belgium Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 45: Denmark Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 46: Finland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 47: France Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 48: France Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 49: Germany Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 50: Germany Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 51: Ireland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 52: Italy Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 53: Netherlands Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 54: Norway Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 55: Portugal Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 56: Spain Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 57: Sweden Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 58: Switzerland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 59: UK Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 60: UK Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 61: Eastern Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 62: Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 63: Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 64: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Table 65: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Eastern Europe Countries
  • Table 66: Eastern Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 67: Czech Republic Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 68: Poland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 69: Romania Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 70: Russia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 71: Russia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 72: North America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 73: North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 74: North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 75: Per Capita Average Oncology Drugs Expenditure, 2015-2023, North America Countries
  • Table 76: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, North America Countries
  • Table 77: North America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 78: Canada Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 79: Mexico Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 80: USA Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 81: USA Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 82: South America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 83: South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 84: South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 85: Per Capita Average Oncology Drugs Expenditure, 2015-2023, South America Countries
  • Table 86: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, South America Countries
  • Table 87: South America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 88: Argentina Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 89: Brazil Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 90: Brazil Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 91: Chile Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 92: Colombia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 93: Peru Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 94: Venezuela Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 95: Middle East, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 96: Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 97: Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 98: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Middle East Countries
  • Table 99: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Middle East Countries
  • Table 100: Middle East Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 101: Saudi Arabia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 102: Israel Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 103: Turkey Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 104: UAE Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 105: Africa, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Table 106: Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Table 107: Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 108: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Africa Countries
  • Table 109: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Africa Countries
  • Table 110: Africa Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 111: Egypt Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 112: Nigeria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 113: South Africa Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Table 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 115: Novartis AG Financial Performance
  • Table 116: Gilead Sciences Inc Financial Performance
  • Table 117: Bayer AG Financial Performance
  • Table 118: Takeda Pharmaceticals Financial Performance
  • Table 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Table 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Table 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 123: Global Oncology Drugs Market In 2023- Growth Countries
  • Table 124: Global Oncology Drugs Market In 2023- Growth Segments
  • Table 125: Global Oncology Drugs Market In 2023- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Oncology Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 4: Global Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Oncology Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Oncology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: Global Oncology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Global Oncology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Oncology Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • Figure 12: Per Capita Average Oncology Drugs Market Expenditure, 2015-2023, Global
  • Figure 13: Asia-Pacific, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Asia-Pacific Countries
  • Figure 17: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Asia-Pacific Countries
  • Figure 18: Asia-Pacific Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 19: China Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 20: China Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 21: Australia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 22: Australia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 23: Hong Kong Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 24: India Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 25: India Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 26: Indonesia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 27: Indonesia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 28: Japan Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 29: Japan Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 30: Malaysia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 31: New Zealand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 32: Philippines Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 33: Singapore Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 34: South Korea Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 35: Thailand Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 36: Vietnam Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 37: Western Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 38: Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 39: Western Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 40: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Western Europe Countries
  • Figure 41: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Western Europe Countries
  • Figure 42: Western Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 43: Austria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 44: Belgium Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 45: Denmark Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 46: Finland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 47: France Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 48: France Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 49: Germany Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 50: Germany Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 51: Ireland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 52: Italy Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 53: Netherlands Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 54: Norway Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 55: Portugal Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 56: Spain Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 57: Sweden Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 58: Switzerland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 59: UK Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 60: UK Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 61: Eastern Europe, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 62: Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 63: Eastern Europe, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 64: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Eastern Europe Countries
  • Figure 65: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Eastern Europe Countries
  • Figure 66: Eastern Europe Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 67: Czech Republic Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 68: Poland Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 69: Romania Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 70: Russia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 71: Russia Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 72: North America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 73: North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 74: North America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 75: Per Capita Average Oncology Drugs Expenditure, 2015-2023, North America Countries
  • Figure 76: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, North America Countries
  • Figure 77: North America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 78: Canada Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 79: Mexico Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 80: USA Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 81: USA Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 82: South America, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 83: South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 84: South America, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 85: Per Capita Average Oncology Drugs Expenditure, 2015-2023, South America Countries
  • Figure 86: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, South America Countries
  • Figure 87: South America Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 88: Argentina Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 89: Brazil Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 90: Brazil Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 91: Chile Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 92: Colombia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 93: Peru Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 94: Venezuela Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 95: Middle East, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 96: Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 97: Middle East, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 98: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Middle East Countries
  • Figure 99: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Middle East Countries
  • Figure 100: Middle East Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 101: Saudi Arabia Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 102: Israel Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 103: Turkey Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 104: UAE Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 105: Africa, Oncology Drugs Market, 2019, By Country, Value ($ Billion)
  • Figure 106: Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • Figure 107: Africa, Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 108: Per Capita Average Oncology Drugs Expenditure, 2015-2023, Africa Countries
  • Figure 109: Cancer Prevalence Rate, Oncology Drugs Market, Oncology Drugs Market/Cancer Prevalence Rate, 2019, Africa Countries
  • Figure 110: Africa Oncology Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 111: Egypt Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 112: Nigeria Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 113: South Africa Oncology Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • Figure 114: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 115: Novartis AG Financial Performance
  • Figure 116: Gilead Sciences Inc Financial Performance
  • Figure 117: Bayer AG Financial Performance
  • Figure 118: Takeda Pharmaceticals Financial Performance
  • Figure 119: Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 120: Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • Figure 121: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • Figure 122: Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 123: Global Oncology Drugs Market In 2023- Growth Countries
  • Figure 124: Global Oncology Drugs Market In 2023- Growth Segments
  • Figure 125: Global Oncology Drugs Market In 2023- Growth Strategies
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report
Remdesivir Market Global Report 2020-30: COVID 19 Growth and Change
View Report
Biologics Market - By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), Trends, By Key Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2021
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)